What the data shows
What happens when twins are diagnosed with a rare genetic condition? This question resonates deeply for Jesy Nelson, whose twins, Emma and Bartosz, have been diagnosed with Spinal Muscular Atrophy (SMA), a condition that can severely impact mobility and quality of life. The answer is both heart-wrenching and hopeful, as families navigate the complexities of medical care and support.
Emma and Bartosz were diagnosed with SMA type 1, the most severe form of the disease, which significantly limits their physical abilities. Emma received her diagnosis in 2024, while Bartosz was diagnosed three years earlier in 2021. Unfortunately, both children were diagnosed late, which is a common issue that can lead to lifelong mobility challenges. In the UK, it is estimated that 33 babies may need a wheelchair due to late diagnosis of SMA, highlighting the urgent need for improved screening processes.
The Scottish government has taken a significant step forward by announcing that all babies will be screened for SMA as part of the NHS newborn blood spot test. This initiative aims to prevent late diagnoses and ensure that children receive timely interventions. Currently, the UK is a global outlier in relation to newborn SMA screening, which is already in place in 46 countries, including the US and nearly three-quarters of Europe.
Emma and Bartosz were fortunate to receive gene therapy known as Zolgensma through the NHS. This treatment has the potential to halt the progression of SMA and can even eradicate it if administered early enough. Jesy Nelson and other parents in similar situations express immense gratitude for the advancements in medical science that offer hope to their children. As Rhys Davie, a parent of another child with SMA, shared, “Any moment like that when we can see she’s become stronger is incredible – we just feel so much gratitude and joy.”
Despite the challenges, the community surrounding families affected by SMA is incredibly supportive. Parents like Paola and Urszula have reached out to Jesy, offering words of comfort and understanding. Paola expressed, “I’m sorry you’re going through this. I remember how overwhelming it felt at the beginning.” This sense of community is vital as families navigate the emotional and practical hurdles of raising children with SMA.
Looking ahead, the rollout of SMA screening in England is projected for 2031, which could change the landscape for many families. Until then, the urgency for awareness and advocacy remains high. Jesy Nelson’s story is a poignant reminder of the importance of early diagnosis and the impact it can have on the lives of children and their families.
As the conversation around SMA continues to grow, there is hope that more families will be spared the heartache of late diagnoses. The journey for Jesy and her twins is ongoing, and while they face significant challenges, the support from the community and advancements in medical care provide a beacon of hope for the future.
